Hyperparathyroidism, Primary: Clinical Trials

1 trial for Hyperparathyroidism, Primary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Withdrawn 1

Follow Hyperparathyroidism, Primary: new trials by email Literature Review of Hyperparathyroidism, Primary trials Research Report on Hyperparathyroidism, Primary

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects of Alendronate After Cure of Primary Hyperparathyroidism
Alendronate 70mg weekly - Hyperparathyroidism
Phase 4WithdrawnColumbia University2006-07-012011-11-16

Narrower conditions

Hypercalcemia (1)  ·  Hyperparathyroidism (1)  ·  Osteoporosis (1)

Broader conditions

Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Calcium Metabolism Disorders (1)  ·  Endocrine System Diseases (1)  ·  Metabolic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Parathyroid Diseases (1)  ·  Water-Electrolyte Imbalance (1)

Interventions

Alendronate (1)

Sponsors

Columbia University (1)

Countries

United States (1)

Top investigators

Shonni J. Silverberg, MD (1)